Tab Adult, adolescent & childn (at least 25 kg) 300 mg daily or 150 mg bd. Childn ≥20 kg to <25 kg ½ tab in the morning & 1 tab in the evening. 14 to <20 kg ½ tab bd or 1 tab once daily. Oral solnAdult & adolescent (at least 25 kg) 30 mL once daily or 15 ml bd. Childn >3 mth (<25 kg) 4 mg/kg bd. Max: 300 mg daily.
Not recommended for use as monotherapy. Discontinue use if pancreatitis occurs. Lactic acidosis/severe hepatomegaly w/ steatosis. Immune reconstitution syndrome. Manage serum lipids & blood glucose. Periodic monitoring of LFTs & HBV replication markers upon discontinuation in patients w/ HIV & HBV co-infection. Moderate to severe renal impairment, risk factor for liver disease. Pregnancy. Not to be used during lactation. Elderly. Oral soln: Diabetic patients. Monitor HIV-1 viral load w/ sorbitol-containing drugs.
J05AF05 - lamivudine ; Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
Sign Out
